Analgesics & the WHO pain ladder
also: opioids · morphine · WHO analgesic ladder · codeine · naloxone · PCA
Overview
Acute, post-operative and palliative pain management — the WHO ladder, the opioids, and the safety points (naloxone, renal impairment, codeine pharmacogenetics).
Mechanism
Step the WHO ladder: non-opioid (paracetamol/NSAID) → weak opioid (codeine/dihydrocodeine/tramadol) → strong opioid (morphine/oxycodone/fentanyl). Opioids agonise µ-opioid receptors (Gi → ↓cAMP, ↓neuronal excitability) → analgesia + the class effects. Naloxone is a competitive opioid antagonist (reversal).
Indications
- Acute / post-operative pain (incl. PCA)
- Chronic & cancer pain (WHO ladder)
- Opioid overdose reversal (naloxone)
The agents
PO/IV/SC
Standard; active metabolites accumulate in renal impairment → use oxycodone/alfentanil if eGFR low.
Less active-metabolite accumulation; renal impairment.
transdermal/IV/buccal
Transdermal for stable chronic pain; safer in renal failure.
Codeine is a prodrug (CYP2D6) — avoid <12y / variable metabolisers; tramadol also lowers seizure threshold + serotonergic.
IV/IM/intranasal
Short half-life — repeat/infuse; titrate to respiratory rate, not full reversal in palliative patients.
Adverse effects
The dangerous effect; reverse with naloxone.
Co-prescribe a laxative — tolerance does NOT develop.
Cautions & contraindications
Active metabolite (M6G) accumulation → toxicity; use oxycodone/fentanyl/alfentanil.
CYP2D6 ultra-rapid metabolism → respiratory depression.
Interactions
- Additive sedation/respiratory depression with benzodiazepines, gabapentinoids, alcohol
- Tramadol + SSRIs → serotonin syndrome
Monitoring & kinetics
Respiratory rate, sedation, pain score; bowels (laxative); convert doses carefully (oral→SC morphine ÷2; opioid switch tables)
PO/IV/SC/transdermal. Always co-prescribe an antiemetic + laxative when starting strong opioids.
Source: WHO — Analgesic ladder · BNF — Opioid analgesics